We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Drafts New Guidance for NDAs of Addictive Drugs
FDA Drafts New Guidance for NDAs of Addictive Drugs
January 29, 2010
New FDA draft guidance may expand the definition of potentially addictive drugs and says drugmakers developing such products should include assessments of that potential in NDAs.